The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Infections Caused by Pseudomonas aeruginosa
Abstract
Pseudomonas aeruginosa has emerged as an important pathogen during the past two decades. It causes between 10% and 20% of infections in most hospitals. Pseudomonas infection is especially prevalent among patients with burn wounds, cystic fibrosis, acute leukemia, organ transplants, and intravenous-drug addiction. P. aeruginosa is a common nosocomial contaminant, and epidemics have been traced to many items in the hospital environment. Patients who are hospitalized for extended periods are frequently colonized by this organism and are at increased risk of developing infection. The most serious infections include malignant external otitis, endophthalmitis, endocarditis, meningitis, pneumonia, and septicemia. The likelihood of recovery from pseudomonas infection is related to the severity of the patient's underlying disease process. The introduction of the antipseudomonal aminoglycosides and penicillins has improved substantially the prognosis of these infections. Ticarcillin and carbenicillin have been especially beneficial in neutropenic patients; however, prompt institution of therapy is mandatory for optimal benefit. Many new drugs with antipseudomonal activity, including penicillins, cephalosporins, and other beta-lactams, have been introduced in recent years and offer the potential for new approaches to therapy for these infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
JOHANSON, W. G., PIERCE, A. K., SANFORD, J. P., & THOMAS, G. D. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-5-701 · Cited by 1,087
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595
Production and Characterization of the Slime Polysaccharide of Pseudomonas aeruginosa
Evans, L. R., & Linker, A. (1973) · Journal of Bacteriology · doi:10.1128/jb.116.2.915-924.1973 · Cited by 428
DuPONT, H. L., & SPINK, W. W. (1969) · Medicine · doi:10.1097/00005792-196907000-00003 · Cited by 418
Fever and infection in leukemic patients.A study of 494 consecutive patients
Bodey, G. P., Rodriguez, V., Chang, H.-Y., & Narboni, G. (1978) · Cancer · doi:10.1002/1097-0142(197804)41:4<1610::aid-cncr2820410452>3.0.co;2-b · Cited by 325
Self-citationPseudomonas aeruginosa : Growth in Distilled Water from Hospitals
Favero, M. S., Carson, L. A., Bond, W. W., & Petersen, N. J. (1971) · Science · doi:10.1126/science.173.3999.836 · Cited by 291
Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa
Schwarzmann, S., & Boring, J. R. (1971) · Infection and Immunity · doi:10.1128/iai.3.6.762-767.1971 · Cited by 236
Adult pneumonia in a general hospital. Etiology and host risk factors
Sullivan, R. J. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.129.6.935 · Cited by 209
Pollack, M., & Young, L. S. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109300 · Cited by 207
Young, L. S., & Armstrong, D. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.3.257 · Cited by 202
Schultz, D. R., & Miller, K. D. (1974) · Infection and Immunity · doi:10.1128/iai.10.1.128-135.1974 · Cited by 197
Hodgin, U. G., & Sanford, J. P. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90118-x · Cited by 181
Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia
Anderson, E. T., Young, L. S., & Hewitt, W. L. (1978) · Chemotherapy · doi:10.1159/000237759 · Cited by 173
Lau, W. K., Young, L. S., Black, R. E., Winston, D. J., Linné, S. R., Weinstein, R. J., & Hewitt, W. L. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90669-6 · Cited by 161
Recent Experience with Bacillemia Due to Gram-Negative Organisms
Myerowitz, R. L., Medeiros, A. A., & O’Brien, T. (1971) · The Journal of Infectious Diseases · doi:10.1093/infdis/124.3.239 · Cited by 161
Neu, H. C., Aswapokee, N., Aswapokee, P., & Fu, K. P. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.2.273 · Cited by 160
Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with Gentamicin
Jackson, G. G., & Rilf, L. J. (1971) · The Journal of Infectious Diseases · doi:10.1093/infdis/124.supplement_1.s185 · Cited by 136
CENTRAL NERVOUS SYSTEM INFECTIONS IN PATIENTS WITH CANCER
Chernik, N. L., Armstrong, D., & Posner, J. B. (1973) · Medicine · doi:10.1097/00005792-197311000-00003 · Cited by 132
Introduction of Pseudomonas aeruginosa into a Hospital via Vegetables
Kominos, S. D., Copeland, C. E., Grosiak, B., & Postic, B. (1972) · Applied Microbiology · doi:10.1128/am.24.4.567-570.1972 · Cited by 126
Evaluation of Leukocyte Chemotaxis In Vitro in Thermally Injured Patients
Warden, G. D., Mason, A. D., & Pruitt, B. A. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107815 · Cited by 120
Current Problems in the Treatment of Infective Endocarditis Due to Pseudomonas aeruginosa
Reyes, M. P., & Lerner, A. M. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.2.314 · Cited by 117
Pseudomonas Colonization in Cystic Fibrosis
Kulczycki, L. L. (1978) · JAMA · doi:10.1001/jama.1978.03290010034018 · Cited by 105
Bacteremia in a community hospital: spectrum and mortality
Setia, U. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.12.1698 · Cited by 99
Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum.
Ziegler, E. J., McCutchan, J. A., Douglas, H., et al. (1975) · PubMed · Cited by 90
Reyes, M. P., Brown, W. J., & Lerner, A. M. (1978) · Medicine · doi:10.1097/00005792-197801000-00004 · Cited by 87
Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases
Gray, L., & Kreger, A. S. (1979) · Infection and Immunity · doi:10.1128/iai.23.1.150-159.1979 · Cited by 84
A Proposed Antigenic Schemia for the Identification of Strains of Pseudomonas Aeruginosa
Verder, E., & Evans, J. (1961) · The Journal of Infectious Diseases · doi:10.1093/infdis/109.2.183 · Cited by 82
Pathologic features of pseudomonal pneumonia.
Fetzer, A. E., Werner, A., & Hagstrom, J. W. C. (1967) · PubMed · doi:10.1164/arrd.1967.96.6.1121 · Cited by 79
Appelbaum, F. R., Bowles, C. A., Makuch, R., & Deisseroth, A. (1978) · Blood · doi:10.1182/blood.v52.2.323.323 · Cited by 78
Archer, G. L., & Fekety, F. R. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.3.327 · Cited by 72
MUCOID PSEUDOMONAS qRUGINOSA IN PATIENTS WITH CHRONIC ILLNESSES
Doggett, R. G. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90973-1 · Cited by 72
Composition of Pseudomonas aeruginosa slime
Brown, M. R., Foster, J. H. S., & Clamp, J. R. (1969) · Biochemical Journal · doi:10.1042/bj1120521 · Cited by 65
Lowbury, E. J. L., Babb, J. R., & Roe, E. A. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92469-5 · Cited by 58
Pseudomonas aeruginosa pneumonia in adults.
Rose, H. D., Heckman, M. G., & Unger, J. D. (1973) · PubMed · doi:10.1164/arrd.1973.107.3.416 · Cited by 57
A descriptive study of nosocomial bacteremias at The Johns Hopkins Hospital, 1968--1974.
Spengler, R., Greenough, W. B., & Pd, S. (1978) · PubMed · Cited by 56
Pseudomonas Vertebral Osteomyelitis in Heroin Addicts
WIESSEMAN, G. J., Wood, V. E., & Kroll, L. L. (1973) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197355070-00008 · Cited by 54
Type-Specific vs. Cross-Protective Vaccination for Gram-Negative Bacterial Pneumonia
Pennington, J. E., & Menkes, E. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/144.6.599 · Cited by 50
Pseudomonas aeruginosa bacteremia in patients with neoplastic disease
Fishman, L. S., & Armstrong, D. (1972) · Cancer · doi:10.1002/1097-0142(197209)30:3<764::aid-cncr2820300326>3.0.co;2-g · Cited by 50
Armstrong, A. V., Stewart-Tull, D. E. S., & Roberts, J. S. (1971) · Journal of Medical Microbiology · doi:10.1099/00222615-4-2-249 · Cited by 43
Complement-mediated phagocytosis of Pseudomonas aeruginosa.
Peterson, P. K., Kim, Y., Schmeling, D. J., et al. (1978) · PubMed · Cited by 43
Properdin and the defence of burns against infection
Lowbury, E. J. L., Ricketts, C. R., Hall, M., Hurst, L., & Lilly, H. A. (1957) · Journal of Hygiene · doi:10.1017/s0022172400037153 · Cited by 28
Friis, B. (1979) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1979.11.issue-3.07 · Cited by 26
Topical and Systemic Antimicrobial Agents in Burns
Ollstein, R. N., & McDonald, C. (1980) · Annals of Plastic Surgery · doi:10.1097/00000637-198011000-00010 · Cited by 20
McCutchan, J. A., Ej, Z., & Braude, A. I. (1979) · PubMed · Cited by 12
Cited by
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
Hueck, C. J. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.2.379-433.1998 · Cited by 2,394
Nelson, K. E., Weinel, C., Paulsen, I. T., Dodson, R. J., Hilbert, H., Martins dos Santos, V. A. P., Fouts, D. E., Gill, S. R., Pop, M., Holmes, M., et al. (2002) · Environmental Microbiology · doi:10.1046/j.1462-2920.2002.00366.x · Cited by 1,340
Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals
Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G., & Ausubel, F. M. (1995) · Science · doi:10.1126/science.7604262 · Cited by 1,339
Metadata
- Authors
- Bodey, G. P., Bolivar, R., Fainstein, V., & Jadeja, L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-03-01
- Volume
- 5
- Issue
- 2
- Pages
- 279-313
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2104493016
- Cited by
- 853
- References
- 45
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.